ORIGIN and rethinking our diabetes classification: Towards precision medicine
Speaker: Hertzel Gerstein 01.10.2021 18:45-19:15 Paris Hall
Speaker: Hertzel Gerstein 01.10.2021 18:45-19:15 Paris Hall
17:40 – 17:43 Welcome Adie Viljoen (UK) 17:43 – 17:51 Early treatment: what are the benefits of early initiation of GLP-1RAs? Tina Vilsbøll (DNK)Juris Meier
19:00 – 19:02 Introduction: The incretin effect revisited Tina Vilsbøll (DNK) 19:02 – 19:12 Contra: Can the incretin effect be restored in people with diabetes?
SUPPPORT STATEMENTSupported by an independent educational grant from Lilly 08:15 – 08:25 Better Metabolic Health with Incretin-based Therapies – Achievements and Ambitions Michael Nauck (GER)
